09:49 AM EST - Bioniche Life Sciences Inc. : announced financial results for its 2010 fiscal year ended June 30, 2010. Consolidated revenues related to Bioniche Animal Health product sales for the fiscal year were $27 million, as compared to $33 million in Fiscal 2009. This 19% decrease is primarily attributed to the economic recession in some markets, which impacted the sales of livestock reproduction products and performance horse products. In spite of these recessionary challenges, the Animal Health business unit continued to generate Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). It should be noted that this is before Research and Development expenditures of $8.6 million, as compared to $12.2 million in Fiscal 2009. Bioniche Life Sciences Inc.
shares T.BNC are trading down $0.01 at $1.24.
